
Long-Term Follow-Up Shows Babies with 'Bubble Boy Disease' Remain Cured
A long-term follow-up study shows that gene therapy for babies with severe combined immunodeficiency (SCID), known as 'Bubble Boy disease,' remains 95% effective in restoring immune function, with children living healthy, normal lives and the therapy nearing FDA approval.

